Laetitia Denbigh
Laetitia Denbigh is a Director Program Lead at Waters Corporation (Wilmslow, UK).
Articles
Advancing Gene Therapy: Enzyme Selection for Effective RNA Oligonucleotide Mapping
Thomas Menneteau;Balasubrahmanyam Addepalli;Tatiana Johnston;Christian Reidy;Matthew Gorton;Jennifer Bouchenna;Nick Pittman;Claire I. Butré ;Damien Mouvet;Laetitia Denbigh;Matthew A. Lauber;Arnaud Delobel
January 3rd 2025New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), continue to make progress in both primate and first-in-human trials. As this progress builds, the industry remains accountable for characterizing these molecules to meet the requirements of regulatory authorities.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
Analyzing Organic Acids in Fruit-Based Kombucha Analogues Using HPLC
Published: November 18th 2024 | Updated: November 19th 2024
LC-HRMS Technology Used to Track Chemical Migration in Reusable Plastic Bottles
Published: July 3rd 2024 | Updated: July 8th 2024
Technology Trends in Separation Science: Data Handling
Published: December 1st 2024 | Updated: January 5th 2025
Advances in Biopharmaceutical Analysis 2024 North America PDF
Published: December 1st 2024 | Updated: January 5th 2025
Advances in Biopharmaceutical Analysis 2024 Europe PDF
Published: October 15th 2024 | Updated: January 5th 2025
What’s New in Reversed-Phase Liquid Chromatography Selectivity? An Update from the Perspective of the Hydrophobic Subtraction Model
